Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden

<div>Plot of the odds ratios (95% confidence intervals) regarding tumor stability (tumor stability refers to stable disease RECIST 1.1, and compared to partial remission, it is referred to as an undesired event).</div>

Radiology Research and Practice

fig3

Figure 3

Figure 3: Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden 

Figure 3 | Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden 